开立医疗
(300633)
| 流通市值：48.25亿 | | | 总市值：78.81亿 |
| 流通股本：2.60亿 | | | 总股本：4.25亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,053,322,517.14 | 480,719,375.08 | 2,308,908,666.51 | 1,459,311,230.15 |
| 营业总成本 | 1,087,875,025.74 | 523,253,650.33 | 2,183,569,025.01 | 1,499,658,882.65 |
| 其他经营收益 | | | | |
| 营业利润 | 8,188,223.75 | -16,811,436.34 | 165,282,780.51 | 9,591,435.58 |
| 利润总额 | 8,197,170.91 | -16,681,991.68 | 164,190,989.93 | 8,957,251.43 |
| 净利润 | 13,776,261.12 | -11,609,434.43 | 197,280,077.3 | 33,511,062.11 |
| 每股收益 | | | | |
| 其他综合收益 | -982,567.04 | 2,090,055.92 | -3,135,975.42 | 9,759,243.34 |
| 综合收益总额 | 12,793,694.08 | -9,519,378.51 | 194,144,101.88 | 43,270,305.45 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,426,982,167.33 | 2,703,428,761.05 | 2,816,015,503.63 | 2,673,062,414.67 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,660,782,495.78 | 1,595,624,830.49 | 1,590,295,354.13 | 1,442,953,795.86 |
| 资产总计 | 4,087,764,663.11 | 4,299,053,591.54 | 4,406,310,857.76 | 4,116,016,210.53 |
| 流动负债: | | | | |
| 流动负债合计 | 813,503,025.89 | 914,129,068.79 | 1,020,168,173.47 | 880,344,233.44 |
| 非流动负债: | | | | |
| 非流动负债合计 | 257,809,315.97 | 121,520,546.54 | 123,652,199.77 | 116,523,459.73 |
| 负债合计 | 1,071,312,341.86 | 1,035,649,615.33 | 1,143,820,373.24 | 996,867,693.17 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,016,452,321.25 | 3,263,403,976.21 | 3,262,490,484.52 | 3,119,148,517.36 |
| 股东权益合计 | 3,016,452,321.25 | 3,263,403,976.21 | 3,262,490,484.52 | 3,119,148,517.36 |
| 负债和股东权益合计 | 4,087,764,663.11 | 4,299,053,591.54 | 4,406,310,857.76 | 4,116,016,210.53 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,255,478,555.82 | 632,208,482.37 | 2,667,234,472.68 | 1,620,769,293.86 |
| 经营活动现金流出小计 | 1,362,069,740.86 | 771,992,711.22 | 2,715,394,038.33 | 2,001,741,353.86 |
| 经营活动产生的现金流量净额 | -106,591,185.04 | -139,784,228.85 | -48,159,565.65 | -380,972,060 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 550,545,119.82 | 448,306,476.84 | 790,383,391.94 | 685,529,722.35 |
| 投资活动现金流出小计 | 583,669,048.61 | 233,619,318.35 | 998,841,842.87 | 359,981,279.26 |
| 投资活动产生的现金流量净额 | -33,123,928.79 | 214,687,158.49 | -208,458,450.93 | 325,548,443.09 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 226,950,758.08 | 28,549,550.39 | 238,642,840.51 | 245,292,590.89 |
| 筹资活动现金流出小计 | 533,952,475.47 | 66,506,142.08 | 329,057,267.65 | 344,117,242.47 |
| 筹资活动产生的现金流量净额 | -307,001,717.39 | -37,956,591.69 | -90,414,427.14 | -98,824,651.58 |
| 汇率变动对现金及现金等价物的影响 | -19,093,766.49 | -10,187,794.59 | 2,891,504.89 | 378,972.51 |
| 现金及现金等价物净增加额 | -465,810,597.71 | 26,758,543.36 | -344,140,938.83 | -153,869,295.98 |
| 期末现金及现金等价物余额 | 712,610,236.23 | 1,205,179,377.3 | 1,178,420,833.94 | 1,368,692,476.79 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -465,810,597.71 | - | -344,140,938.83 | - |
最新报告期：2026-09-17| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国泰海通 | 余文心,赵峻峰 | 0.57 | 0.87 | 1.23 | 2026-09-17 |
| 东海证券 | 杜永宏 | 0.72 | 0.96 | 1.23 | 2026-09-02 |
| 兴业证券 | 孙媛媛,董晓洁,黄翰漾 | 0.66 | 0.93 | 1.21 | 2026-08-30 |
| 国信证券 | 凌珑,彭思宇,陈曦炳 | 0.77 | 0.98 | 1.25 | 2026-08-27 |
| 招商证券 | 梁广楷,许菲菲,郭子娴 | 0.72 | 0.93 | 1.21 | 2026-08-27 |